
|Articles|August 16, 2018
Risuteganib for the treatment of DME
Advertisement
Peter Kaiser, MD, shares how risuteganib (Luminate, Allegro) can help with the treatment of DME when anti-VEGF treatment isn't a viable option. He presented his research in Vancouver, British Columbia, during the 2018 annual meeting of the American Society of Retina Specialists.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
FDA expands faricimab label to include treatment of macular edema secondary to retinal vein occlusion beyond 6 months
2
Tattoo-associated uveitis: An emerging eye health challenge
3
Directional OCT provides biomarkers of Parkinson’s Disease in the outer retina
4
FDA grants RMAT designation to RTx-015 optogenetic gene therapy for retinitis pigmentosa
5


























